Where Are We Going? Future Perspectives on Navigating the Treatment Paradigm in Transplant-Eligible NDMM

Opinion
Video

Panelists discuss how the evolving treatment landscape for patients with transplant-eligible newly diagnosed multiple myeloma (NDMM) is being shaped by emerging data on optimal treatment sequencing strategies, both in frontline settings and subsequent lines of therapy.

Video content above is prompted by the following:

  1. As treatments continue to evolve, how do you see the future treatment landscape changing for patients with transplant-eligible NDMM?
    1. How do the data inform your consideration of treatment sequencing beyond the front line?
Recent Videos
4 experts are featured in this series.
3 experts are featured in this series.
Related Content